搜索结果

• Lumito在印度获得专利批准 - TradingView
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 17:21
• 韩国专利代理人协会29日发表声明 欢迎宪法相关决定
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 17:21
• Cartherics公司在中国获得TAG-72 CAR基因修饰干细胞关键专利
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 17:21
• 快速采用时代下的人工智能采购合同 - IPWatchdog.com
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 16:20
• 2025年英国法院专利年度回顾报告
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 16:20
• IPR-intensive industries drive Europe’s economy, trade and startup funding
  <p>New study shows these industries generate almost half of EU GDP, pay higher wages and drive most EU trade</p>
  来源: https://www.epo.org/en/news-events/news/feed · 时间: 2026-01-29 16:20
• 联邦巡回上诉法院发回重审后，PTAB维持博士伦公司专利有效
  The Patent Trial and Appeal Board (PTAB) has reaffirmed its decision that MSN Laboratories did not demonstrate the invalidity of a drug patent held by Bausch Health Ireland Ltd. This ruling comes afte
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 14:16
• USPTO要求对中国公司1.9万款应用实施“严厉制裁”
  USPTO Seeks ‘Serious Sanctions’ For Chinese Co.’s 19K Apps By Editorial Team The U.S. Patent and Trademark Office (USPTO) has taken a firm stance against a China-based company for submitting over 19,0
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 14:16
• USPTO要求对中国公司19000个应用程序实施“严厉制裁”
  USPTO Seeks ‘Serious Sanctions’ For Chinese Co.’s 19K Apps By Editorial Team The U.S. Patent and Trademark Office (USPTO) has taken a firm stance against a China-based company for submitting over 19,0
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 14:16
• 机器人辅助手术的崛起：创新、影响与知识产权 - 英国专利视角
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 14:16
• 苹果因Continuity Camera功能遭起诉：Reincubate指控其“Sherlocking”行为及专利侵权
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 14:16
• 韩国在全球专利申请量中排名第四
  来源: https://watch.patwatch.com/featured · 时间: 2026-01-29 13:14
• Chancery Awards $50M To Arxada In Trade Secrets Case
  Chancery Awards $50M To Arxada In Trade Secrets Case By Editorial Team Chemicals company Arxada has been granted over $50 million in damages and expenses by Delaware’s Court of Chancery in a lawsuit w
  来源: https://iipla.org/category/ip-news/ · 时间: 2026-01-29 13:11
• Chancery Awards $50M To Arxada In Trade Secrets Case
  Chancery Awards $50M To Arxada In Trade Secrets Case By Editorial Team Chemicals company Arxada has been granted over $50 million in damages and expenses by Delaware’s Court of Chancery in a lawsuit w
  来源: https://iipla.org/news/ · 时间: 2026-01-29 13:11
• Chancery Awards $50M To Arxada In Trade Secrets Case
  Chancery Awards $50M To Arxada In Trade Secrets Case By Editorial Team Chemicals company Arxada has been granted over $50 million in damages and expenses by the Delaware Court of Chancery in a lawsuit
  来源: https://iipla.org/category/ip-news/ · 时间: 2026-01-29 13:10
• Chancery Awards $50M To Arxada In Trade Secrets Case
  Chancery Awards $50M To Arxada In Trade Secrets Case By Editorial Team Chemicals company Arxada has been granted over $50 million in damages and expenses by the Delaware Court of Chancery in a lawsuit
  来源: https://iipla.org/news/ · 时间: 2026-01-29 13:10
• After Fed. Circ. Remand, PTAB Again Backs Bausch Patent
  After Fed. Circ. Remand, PTAB Again Backs Bausch Patent By Editorial Team The Patent Trial and Appeal Board (PTAB) has reaffirmed its decision that MSN Laboratories failed to demonstrate the invalidit
  来源: https://iipla.org/category/ip-news/ · 时间: 2026-01-29 13:09
• After Fed. Circ. Remand, PTAB Again Backs Bausch Patent
  After Fed. Circ. Remand, PTAB Again Backs Bausch Patent By Editorial Team The Patent Trial and Appeal Board (PTAB) has reaffirmed its decision that MSN Laboratories failed to demonstrate the invalidit
  来源: https://iipla.org/news/ · 时间: 2026-01-29 13:09
• PTAB Upholds Bausch Patent Following Federal Circuit Remand
  PTAB Upholds Bausch Patent Following Federal Circuit Remand By Editorial Team The Patent Trial and Appeal Board (PTAB) has reaffirmed its decision that MSN Laboratories did not demonstrate the invalid
  来源: https://iipla.org/category/ip-news/ · 时间: 2026-01-29 13:06
• PTAB Upholds Bausch Patent Following Federal Circuit Remand
  PTAB Upholds Bausch Patent Following Federal Circuit Remand By Editorial Team The Patent Trial and Appeal Board (PTAB) has reaffirmed its decision that MSN Laboratories did not demonstrate the invalid
  来源: https://iipla.org/news/ · 时间: 2026-01-29 13:06